Author

Liurui Dou

Observed name: Dou, Liurui

Institutions: Capital Medical University, Beijing Friendship Hospital

Observed institutions: Capital Medical University, Zhengzhou University, Henan Provincial People's Hospital, Henan Cancer Hospital, Beijing Friendship Hospital, Zhengzhou People's Hospital

ORCID: 0000-0002-6220-5904

Observed ORCID: 0000-0002-6220-5904

OpenAlex ID: A5088587258

A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia

2021 · Juanjuan Song, Baojun Shang, et al. · Leukemia Research · 9

Epstein–Barr virus infection plays a crucial role in triggering hemophagocytic lymphohistiocytosis in patients with X-linked inhibitor of apoptosis protein deficiency

2025 · Lin Shi, Liurui Dou, et al. · Hematology · 4

Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia

2021 · Yanru Pei, Mingyue Shi, et al. · Cancer Management and Research · 4

Clinical and prognostic significance of whole blood Epstein-Barr virus DNA in patients with primary hemophagocytic lymphohistiocytosis: a retrospective observational study from China

2025 · Liurui Dou, Jia Zhang, et al. · Annals of Hematology · 3

Acute promyelocytic leukemia with myelofibrosis

2021 · Mengyu Xiao, Ling Qin, et al. · Medicine · 3

Etiological stratification and prognostic assessment of haemophagocytic lymphohistiocytosis by machine learning on onco-mNGS data and clinical data

2024 · Lin Wu, Xuefang Cao, et al. · Frontiers in Immunology · 2

Differential effects of recombinant human thrombopoietin on clinical outcomes in CD7-positive and CD7-negative acute myeloid leukaemia

2023 · Xiaobai Sun, Xiaobai Sun, et al. · Leukemia Research

Works count: 8

Citation count: 25

H-index: 3

I10-index: